Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

NCT06464939 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Dentin Hypersensitivity

Interventions

DRUG: KH001
DRUG: Placebo

Sponsor

HysensBio Co., Ltd

Collaborators

[object Object]